Top Tweets for #addontherapy

Dr. José Luis Neyro @doctorneyro

over 1 year ago

Oral #cholecalciferol #100 000IU every #2weeks significantly reduced disease #activity in #CIS and early relapsing-remitting #MS. These results warrant further #investigation, including the potential role of pulse #highdose #vitaminD as #addontherapy. https://t.co/5Bl83IGzEC

0

2

0

1

73

Epilepsia Open @EpilepsiaOpen

almost 2 years ago

Key point: All add-on antiseizure medications (ASMs) approved for the treatment of #epilepsy showed that they were effective compared to placebo. https://t.co/EjmHz6vyvz #ilae #addontherapy #antiseizuremedication #metaanalysis #focalepilepsy @IlaeWeb @epilepsiaopen @WileyNeuro

EpilepsiaOpen's tweet photo. Key point: All add-on antiseizure medications (ASMs) approved for the treatment of #epilepsy showed that they were effective compared to placebo.
https://t.co/EjmHz6vyvz

#ilae #addontherapy #antiseizuremedication #metaanalysis #focalepilepsy @IlaeWeb @epilepsiaopen @WileyNeuro https://t.co/tGyTwyHNNN

0

7

2

2

493

Epilepsia @EpilepsiaJourn

over 3 years ago

Should substitution monotherapy or combination therapy be used after failure of the first antiseizure medication? Observations from a 30‐year cohort study https://t.co/qMYqFz7z62 #epilepsy #antiseizuremedication #addontherapy #monotherapy @IlaeWeb @epilepsiajourn @WileyNeuro

EpilepsiaJourn's tweet photo. Should substitution monotherapy or combination therapy be used after failure of the first antiseizure medication? Observations from a 30‐year cohort study https://t.co/qMYqFz7z62

#epilepsy #antiseizuremedication #addontherapy #monotherapy @IlaeWeb @epilepsiajourn @WileyNeuro https://t.co/Z1WmL7YLXE

0

15

9

1

4K

payers' insights @payers_insights

about 9 years ago

#FDA approves #Newron's drug as #addontherapy for #Parkinson https://t.co/1BVhVt1TSA

payers_insights's tweet photo. #FDA approves #Newron's drug as #addontherapy for #Parkinson https://t.co/1BVhVt1TSA https://t.co/d5185sUL8G

0

0

0

0

0

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users